Related Experiment Video
Updated: Mar 14, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Predictive Modeling of Ocular Pharmacokinetics and Adverse Effects
Leo Ghemtio, Henri Xhaard, Arto Urtti
1Department of Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, P.O. Box: 56, Helsinki, Finland.
Abstract:
Treatment of ocular disorders is a challenge due to the difficulty of delivering drugs to the target tissues within the eye at sufficient concentrations to produce a therapeutic effect. The cornea and the blood-retinal barrier, comprising of the retinal pigment epithelium and the retinal capillaries, are the main barriers for delivering drugs to treat diseases in the anterior and posterior parts of the eye, respectively. The eye has a rich blood supply and relatively small mass, and drugs can distribute from the systemic blood circulation to the choroid through the fenestrated choroidal blood vessels, but further permeation into the eye is limited by the blood-retinal barrier. Computational prediction of the ocular pharmacokinetics of drugs can help improve drug delivery and predict ocular adverse effects resulting from ocular or systemic drugs. Computational models predicting ocular adverse effects of drugs are still scarce, even though prediction of eye irritation and corrosion of chemicals has been well studied as a consequence of recent European Union legislation. Predictive modeling of adverse effects suffers from the wide distribution of data resources, but databases that integrate data on adverse effects, drugs, targets and other related biological data from different sources offer improved prospects for predictive modeling.
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Ophthalmic Drug Delivery Systems
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Analysis of Population Pharmacokinetic Data
Pharmacodynamic Models: Additive and Proportional Drug Effect Model

